Annual report
3840.TEDINET S100YKGU
Period2025-04-01 → 2026-03-31
Filed2026-06-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 133
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.4bn | 2025-04-01 → 2026-03-31 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales |
| Revenue | ¥2.3bn | 2023-04-01 → 2024-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.0bn | 2022-04-01 → 2023-03-31v | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.1bn | 2021-04-01 → 2022-03-31v | Cons. | Net sales (5-year summary) |
| Operating income | −¥774m | 2025-04-01 → 2026-03-31 | Cons. | Operating income |
| Operating income | −¥208m | 2024-04-01 → 2025-03-31 | Cons. | Operating income |
| Ordinary income | −¥961m | 2025-04-01 → 2026-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥229m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥168m | 2023-04-01 → 2024-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥224m | 2022-04-01 → 2023-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥737m | 2021-04-01 → 2022-03-31v | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥269m | 2024-04-01 → 2025-03-31 | Cons. | Income before income taxes |
| Net income (owners) | −¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥176m | 2023-04-01 → 2024-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥256m | 2022-04-01 → 2023-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥746m | 2021-04-01 → 2022-03-31v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥1.3bn | 2025-04-01 → 2026-03-31 | Cons. | Profit loss |
| Net income | −¥277m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss |
| Total assets | ¥2.5bn | at 2026-03-31 | Cons. | Assets |
| Total assets | ¥3.3bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥1.7bn | at 2024-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.5bn | at 2023-03-31v | Cons. | Total assets (5-year summary) |
| Total assets | ¥1.3bn | at 2022-03-31v | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥621m | at 2026-03-31 | Cons. | Liabilities |
| Total liabilities | ¥777m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2026-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥1.2bn | at 2024-03-31v | Cons. | Net assets |
| Net assets / equity | ¥1.1bn | at 2023-03-31v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥470m | at 2022-03-31v | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥357m | at 2026-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥155m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥357m | at 2026-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥155m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥297m | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥173m | at 2023-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥345m | at 2022-03-31v | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥435m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥539m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥77m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥352m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥836m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥319m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥525m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥87m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥114m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥24m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥957m | 2025-04-01 → 2026-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥914m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥288m | 2023-04-01 → 2024-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥281m | 2022-04-01 → 2023-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥999m | 2021-04-01 → 2022-03-31v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-16.52 | 2025-04-01 → 2026-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-4.36 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.31 | 2023-04-01 → 2024-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-5.46 | 2022-04-01 → 2023-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-20.95 | 2021-04-01 → 2022-03-31v | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥23.05 | at 2026-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥33.47 | at 2025-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥21.2 | at 2024-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥20.91 | at 2023-03-31v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥12.4 | at 2022-03-31v | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 75.4% | at 2026-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 75.5% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 71.2% | at 2024-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 74.3% | at 2023-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 36.0% | at 2022-03-31v | Cons. | Equity to asset ratio (5-year summary) |
| Employees | 50 | at 2026-03-31 | Cons. | Number of employees |
| Employees | 61 | at 2025-03-31 | Cons. | Number of employees |
| Employees | 46 | at 2024-03-31v | Cons. | Number of employees |
| Employees | 56 | at 2023-03-31v | Cons. | Number of employees |
| Employees | 50 | at 2022-03-31v | Cons. | Number of employees |
| Revenue | ¥144m | 2025-04-01 → 2026-03-31 | Standalone | Net sales |
| Revenue | ¥100m | 2024-04-01 → 2025-03-31 | Standalone | Net sales |
| Revenue | ¥82m | 2023-04-01 → 2024-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥132m | 2022-04-01 → 2023-03-31v | Standalone | Net sales (5-year summary) |
| Revenue | ¥95m | 2021-04-01 → 2022-03-31v | Standalone | Net sales (5-year summary) |
| Operating income | −¥122m | 2025-04-01 → 2026-03-31 | Standalone | Operating income |
| Operating income | −¥109m | 2024-04-01 → 2025-03-31 | Standalone | Operating income |
| Ordinary income | −¥1.2bn | 2025-04-01 → 2026-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥172m | 2024-04-01 → 2025-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥132m | 2023-04-01 → 2024-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥268m | 2022-04-01 → 2023-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥666m | 2021-04-01 → 2022-03-31v | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥186m | 2024-04-01 → 2025-03-31 | Standalone | Income before income taxes |
| Net income | −¥1.5bn | 2025-04-01 → 2026-03-31 | Standalone | Profit loss |
| Net income | −¥182m | 2024-04-01 → 2025-03-31 | Standalone | Profit loss |
| Net income | −¥114m | 2023-04-01 → 2024-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥298m | 2022-04-01 → 2023-03-31v | Standalone | Net income loss (5-year summary) |
| Net income | −¥1.1bn | 2021-04-01 → 2022-03-31v | Standalone | Net income loss (5-year summary) |
| Total assets | ¥1.9bn | at 2026-03-31 | Standalone | Assets |
| Total assets | ¥2.5bn | at 2025-03-31 | Standalone | Assets |
| Total assets | ¥1.1bn | at 2024-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥946m | at 2023-03-31v | Standalone | Total assets (5-year summary) |
| Total assets | ¥982m | at 2022-03-31v | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥293m | at 2026-03-31 | Standalone | Liabilities |
| Total liabilities | ¥39m | at 2025-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.6bn | at 2026-03-31 | Standalone | Net assets |
| Net assets / equity | ¥2.5bn | at 2025-03-31 | Standalone | Net assets |
| Net assets / equity | ¥1.1bn | at 2024-03-31v | Standalone | Net assets |
| Net assets / equity | ¥922m | at 2023-03-31v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥334m | at 2022-03-31v | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥310m | at 2026-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥64m | at 2025-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-19.84 | 2025-04-01 → 2026-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.87 | 2024-04-01 → 2025-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.14 | 2023-04-01 → 2024-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-6.36 | 2022-04-01 → 2023-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-30.54 | 2021-04-01 → 2022-03-31v | Standalone | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥19.7 | at 2026-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥33.19 | at 2025-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥19.15 | at 2024-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥17.46 | at 2023-03-31v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥8.73 | at 2022-03-31v | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 84.8% | at 2026-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 97.7% | at 2025-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 96.2% | at 2024-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 95.1% | at 2023-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 32.8% | at 2022-03-31v | Standalone | Equity to asset ratio (5-year summary) |
| Shares issued | 82,680,236 | at 2026-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 73,377,036 | at 2025-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 56,309,516 | at 2024-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 51,509,516 | at 2023-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 36,944,500 | at 2022-03-31v | Standalone | Total number of issued shares (5-year summary) |
| Employees | 9 | at 2026-03-31 | Standalone | Number of employees |
| Employees | 8 | at 2025-03-31 | Standalone | Number of employees |
| Employees | 3 | at 2024-03-31v | Standalone | Number of employees |
| Employees | 4 | at 2023-03-31v | Standalone | Number of employees |
| Employees | 12 | at 2022-03-31v | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2026-03-31 | −¥23m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2026-03-31 | −¥23m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2026-03-31 | −¥160m |
| AI Technologyreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥50m |
| AI Technologyreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥50m |
| AI Technologyreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥167m |
| Beauty And Wellness Businessreportable segment | employees | at 2026-03-31 | 11 pure |
| Beauty And Wellness Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥856m |
| Beauty And Wellness Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥856m |
| Beauty And Wellness Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥82m |
| Cosmetics Businessreportable segment | employees | at 2026-03-31 | 15 pure |
| Cosmetics Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥949m |
| Cosmetics Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥949m |
| Cosmetics Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥248m |
| Investment Businessreportable segment | employees | at 2026-03-31 | 1 pure |
| Investment Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥40m |
| Investment Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥40m |
| Investment Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | ¥38m |
| Market Expansion Businessreportable segment | employees | at 2026-03-31 | 2 pure |
| Market Expansion Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥2m |
| Market Expansion Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥2m |
| Market Expansion Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥50,000 |
| Market Expansion Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥37m |
| Regenerative Medicine Related Businessreportable segment | employees | at 2026-03-31 | 10 pure |
| Regenerative Medicine Related Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥489m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥465m |
| Regenerative Medicine Related Businessreportable segment | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥23m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥54m |
| Sustainable Businessreportable segment | employees | at 2026-03-31 | 3 pure |
| Sustainable Businessreportable segment | revenue | 2025-04-01 → 2026-03-31 | ¥8m |
| Sustainable Businessreportable segment | revenue external | 2025-04-01 → 2026-03-31 | ¥8m |
| Sustainable Businessreportable segment | segment profit | 2025-04-01 → 2026-03-31 | −¥64m |
| —segment total | revenue | 2025-04-01 → 2026-03-31 | ¥2.4bn |
| —segment total | revenue external | 2025-04-01 → 2026-03-31 | ¥2.4bn |
| —segment total | revenue intersegment | 2025-04-01 → 2026-03-31 | ¥23m |
| —segment total | segment profit | 2025-04-01 → 2026-03-31 | −¥614m |
| Reconciling Itemsreconciling | segment profit | 2024-04-01 → 2025-03-31 | −¥126m |
| AI Technologyreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥6m |
| AI Technologyreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥6m |
| AI Technologyreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥11m |
| Beauty And Wellness Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Beauty And Wellness Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥1.0bn |
| Beauty And Wellness Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥42m |
| Cosmetics Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥799m |
| Cosmetics Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥799m |
| Cosmetics Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥44m |
| Investment Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥12m |
| Investment Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥12m |
| Investment Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | ¥12m |
| Market Expansion Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥8m |
| Market Expansion Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥8m |
| Market Expansion Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥5m |
| Regenerative Medicine Related Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥364m |
| Regenerative Medicine Related Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥364m |
| Regenerative Medicine Related Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥38m |
| Sustainable Businessreportable segment | revenue | 2024-04-01 → 2025-03-31 | ¥22m |
| Sustainable Businessreportable segment | revenue external | 2024-04-01 → 2025-03-31 | ¥22m |
| Sustainable Businessreportable segment | segment profit | 2024-04-01 → 2025-03-31 | −¥39m |
| —segment total | revenue | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| —segment total | revenue external | 2024-04-01 → 2025-03-31 | ¥2.3bn |
| —segment total | segment profit | 2024-04-01 → 2025-03-31 | −¥82m |
| Investment Businessreportable segment | employees | at 2026-03-31 | 1 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,345
| Item | Context | Value | Unit |
|---|---|---|---|
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役 星 淳行 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E05674 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 38400 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)パス株式会社 | |
| Filer name in english | FilingDateInstant | PATH corporation | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2025-04-01 | |
| Current period end date | FilingDateInstant | 2026-03-31 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2026-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2024-04-01 | |
| Comparative period end date | FilingDateInstant | 2025-03-31 | |
| Previous fiscal year end date | FilingDateInstant | 2025-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Governance climate change (text) | FilingDateInstant | Text · Plus | |
| Risk management climate change (text) | FilingDateInstant | Text · Plus | |
| Strategy climate change (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets climate change (text) | FilingDateInstant | Text · Plus | |
| Governance human capital (text) | FilingDateInstant | Text · Plus | |
| Risk management human capital (text) | FilingDateInstant | Text · Plus | |
| Strategy human capital (text) | FilingDateInstant | Text · Plus | |
| Policy on development of human resources and internal environment strategy (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets human capital (text) | FilingDateInstant | Text · Plus | |
| Description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Target period description of metrics related to policy on development of human resources and internal environment and targets and performance using such metrics | CurrentYearInstant_Row1Member | Original text (Japanese)2030年３月期 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |